Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to December 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $1.3B |
| Sales growthchange from the year before | +83.4% |
| Operating marginshare of sales left after running the business | -19.9% |
| Net marginshare of sales kept as profit | -19.3% |
| Free-cash-flow marginspare cash generated per $100 of sales | -18.8% |
| Return on invested capitalprofit made on each $100 put into the business | -40.7% |
| Return on equityprofit vs. shareholders' accounting value | -49.9% |
| Interest coverhow many times profit covers interest payments | -3.6x |
| Change in share countnegative = the company is buying back its shares | +45.4% |
3 insiders sold $11.6M (all under pre-arranged plans) on the open market.
| Epstein David RDirector | Sold (plan)Aug 3 | 370 shat $43.40 · $16K |
| Fukushima RyanCEO, Data | Sold (plan)Aug 3 | 23,818 shat $46.19 · $1.1M |
| Lefkofsky Eric PCEO and Chairman · Director · 10% owner | Sold (plan)Jul 28 | 250,000 shat $42.06 · $10.5M |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy